Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Yuri Sanchez-Gonzalez"'
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 433-445 (2023)
Abstract Introduction The aim of this work is to compare real-world outcomes of patients with rheumatoid arthritis (RA) receiving adalimumab (ADA) bio-originator (non-switchers) to those who had switched from ADA bio-originator to an ADA biosimilar (
Externí odkaz:
https://doaj.org/article/141dad39192745bab55f40f357b036b4
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 2, Pp 285-299 (2019)
Abstract Introduction Japan has one of the highest prevalence rate of chronic hepatitis C (CHC) in the industrialized world. However, the burden of CHC treatment is poorly understood. Thus, the healthcare resource utilization and costs of treated ver
Externí odkaz:
https://doaj.org/article/778ede28a15147a78acb15adb46dcd04
Autor:
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 473-484 (2018)
Abstract Introduction Chronic hepatitis C (CHC) infection is associated with extrahepatic manifestations (EHMs) which can affect renal, cardiovascular and other comorbidities. The effect of CHC treatment with short-duration regimens on these EHMs is
Externí odkaz:
https://doaj.org/article/5e15028d125f424282c667c719731947
Autor:
Julian Panes, Anthony Otley, Yuri Sanchez Gonzalez, Kristina Fitzgerald, Wen Zhou, Dapo Ilo, Triza Brion, Muna J. Tahir
Publikováno v:
Digestive Diseases and Sciences. 68:2318-2332
Autor:
Yong Kyun Won, Kyung Sik Kang, Yuri Sanchez Gonzalez, Homie Razavi, Ellen Dugan, Kwang-Hyub Han, Sang Hoon Ahn, Mi Young Jeon, Do Young Kim
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0232186 (2020)
BACKGROUND AND AIMS:Hepatitis C virus (HCV) and its sequelae present a significant source of economic and societal burden. Introduction of highly effective curative therapies has made HCV elimination attainable. The study used a predictive model to a
Externí odkaz:
https://doaj.org/article/21c4f57050a842689d90b3b0d8a54d27
Autor:
Laurent Peyrin-Biroulet, Ethan Arenson, David T Rubin, Corey A Siegel, Scott Lee, F Stephen Laroux, Wen Zhou, Tricia Finney-Hayward, Yuri Sanchez Gonzalez, Alan L Shields
Publikováno v:
Journal of Crohn's and Colitis.
Background and Aims To inform their future use in regulated clinical trials to evaluate treatment efficacy hypotheses, the measurement properties of three histologic indices, Geboes Score (GS), Robarts Histopathology Index (RHI), and Nancy Index (NI)
Autor:
Remo Panaccione, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, Wen Zhou, Dapo Ilo, Dolly Sharma, Yuri Sanchez Gonzalez, Si-Tien Wang
Background Given rapid innovation in advanced therapies for moderately to severely active ulcerative colitis (UC), we investigated their comparative efficacy and safety during induction and maintenance through network meta-analysis. Methods Using Bay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70a63ec594c0873f9d08b56d26c75c0
https://lirias.kuleuven.be/handle/20.500.12942/718639
https://lirias.kuleuven.be/handle/20.500.12942/718639
Autor:
Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D'Haens, Hiroshi Nakase, Julian Panés, Peter D R Higgins, Pascal Juillerat, James O Lindsay, Edward V Loftus, William J Sandborn, Walter Reinisch, Min-Hu Chen, Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Michael A Weinreich, Remo Panaccione
Publikováno v:
The Lancet, 399(10341), 2113-2128. Elsevier Limited
BACKGROUND There is a great unmet need for advanced therapies that provide rapid, robust, and sustained disease control for patients with ulcerative colitis. We assessed the efficacy and safety of upadacitinib, an oral selective Janus kinase 1 inhibi
Autor:
Julián Panés, Jean-Frederic Colombel, Geert R. D’Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward V. Loftus, Silvio Danese, Satoshi Tanida, Yusuke Okuyama, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Toshifumi Hibi, Mamoru Watanabe, Jessica Lefebvre, Tricia Finney-Hayward, Yuri Sanchez Gonzalez, Thao T. Doan, Nael M. Mostafa, Kimitoshi Ikeda, Wangang Xie, Bidan Huang, Joel Petersson, Jasmina Kalabic, Anne M. Robinson, William J. Sandborn
Publikováno v:
Gastroenterology, 162(7), 1891-1910. W.B. Saunders Ltd
BACKGROUND & AIMS: SERENE UC (Study of a Novel Approach to Induction and Maintenance Dosing With Adalimumab in Patients With Moderate to Severe Ulcerative Colitis) evaluated the efficacy of higher adalimumab induction and maintenance dose regimens in
Autor:
Silvio Danese, Jacinda Tran, Geert D’Haens, David T Rubin, Nobuo Aoyama, Wen Zhou, Dapo Ilo, Xuan Yao, Yuri Sanchez Gonzalez, Remo Panaccione
Publikováno v:
Inflammatory Bowel Diseases.
Background This post hoc analysis of a large, phase 3 program evaluated the effects of upadacitinib on fatigue, bowel urgency, and abdominal pain in patients with moderately to severely active ulcerative colitis. Methods Induction data were pooled fr